Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
Learn more about best practices for personal protective equipment during administration, compounding, and spill management of checkpoint inhibitors.
Late or delayed effects are complications caused by cancer treatment that arise months or years after treatment ends. This huddle card highlights the treatment modalities linked to the risk of late effects and provides nursing considerations.
Discover what you can learn on our pain management learning library. Explore resources comprised of both ONS and external content such as webinars, podcasts, books, articles, and more.
Explains the mechanism of action or CDK4/6 inhibitor, a targeted therapy used in the treatment of HR+, HER2- metastatic breast cancer.
Safe administration of high-risk anticancer medications requires careful calculation of ordered doses. Review this huddle card to understand how to calculate body surface area (BSA).
Provides standardized genomic language for oncology nursing practice and promotes understanding of genomic concepts that reflect the state of the science.
After your patient is prescribed a CDK4/6 inhibitor, use this video to ensure that you have completed the appropriate initial assessment and tests.
Intentional, facilitated conversations are opportunities for healthcare staff to gather outside of patient care, meetings with agendas, or formal conferences.
As the use of CAR T-Cell therapy grows, understanding the events involved, the adverse events associated with this therapy and evidence-based management strategies is critical. Use this resource to enhance your understanding of the process behind CAR T-Cell therapy and nursing considerations associated with the treatment.